CARLSBAD, Calif., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Exclusively from Natural Alternatives International, Inc. (NAI), CarnoSyn® Brands portfolio of patented ingredients presents TriBsyn™, a groundbreaking new carnosine booster utilizing CarnoSyn® beta-alanine and patent-pending technology to increase beta-alanine bioavailability and absorption while effectively eliminating beta-alanine related paresthesia. The proprietary TriBsyn™ formulation successfully removes the common paresthesia sensation associated w ...

Medtronic Diabetes expands CGM offerings to meet more people where they are in their diabetes journey DUBLIN, Aug. 7, 2024 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the U.S. Food and Drug Administration (FDA) approval for its Simplera™ continuous glucose monitor (CGM) — the company's first disposable, all-in-one CGM that's half the size of previous Medtronic CGMs. The discreet design simplifies the insertion and wear experience, eliminating the need ...

文章核心观点 - 研究发现细胞外ASC在AA淀粉样变性的发病机理和程度中起关键作用,与IL-1β无关 [1][2][3] - 细胞外ASC与肝脏在炎症期间释放的血清淀粉A(SAA)相互作用,形成支架加速SAA聚集成淀粉样纤维,沉积在组织和器官中 [1][4] - AA淀粉样变性发生于类风湿性关节炎、克罗恩病和炎性肠病等多种慢性炎症性疾病 [1] - 公司正在开发一种创新的炎症体ASC抑制剂IC 100,可抑制多种炎症体内外的ASC和ASC颗粒,从而减弱有害炎症及其持续和蔓延 [1][6] 公司概况 - 公司是一家处于临床阶段的专业生物制药公司,专注于开发治疗炎症和肾脏疾病的首创药物 [7][8] - 公司在快速崛起的炎症体领域拥有一款高度差异化的单克隆抗体IC 100,在肾脏疾病领域也有一款处于2期临床的药物VAR 200 [8] - IC 100的首个适应症是肥胖及其代谢并发症,VAR 200的首个适应症是局灶节段性肾小球硬化症(FSGS) [8] - 公司的两大治疗领域都有"产品内管线"的潜力,可拓展至多个适应症,总可及市场规模超过1000亿美元 [8]

ATHENS, Greece, Aug. 07, 2024 (GLOBE NEWSWIRE) -- OceanPal Inc. (NASDAQ: OP) (the "Company"), a global shipping company specializing in the ownership of vessels, today reported time charter revenues of $6.7 million, a net loss of $8.2 million and net loss attributed to common stockholders of $8.6 million for the second quarter of 2024. This compares to time charter revenues of $5.4 million, a net income of $1.3 million and net income attributed to common stockholders of $483 thousand for the second quarter ...

NEW YORK, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq: ITCI), a biopharmaceutical company focused on the development and commercialization of therapeutics for central nervous system (CNS) disorders, today announced that Sanjeev Narula will join the Company on August 12, 2024 and will serve as Executive Vice President, Chief Financial Officer. Mr. Narula will report to Dr. Sharon Mates, ITCI's Chairman and Chief Executive Officer. Lawrence Hineline, who currently serves as Chief ...

ROSH-HA`AYIN, Israel, Aug. 07, 2024 (GLOBE NEWSWIRE) -- Kornit Digital Ltd. ("Kornit" or the "Company") (Nasdaq: KRNT), a worldwide market leader in sustainable, on-demand, digital fashionX and textile production technologies, today announced that the Company will host an Investor Event on Tuesday, September 10th, 2024 at the Westgate in Las Vegas, NV, in conjunction with its participation at the Printing United trade show. During the Investor Event, the Company will provide insights into its recent busines ...

CAPLYTA Q2 2024 net product sales were $161.3 million, compared to $110.1 million for the same period in 2023, representing a 46% increase CAPLYTA's strong prescription uptake continues: Q2 2024 CAPLYTA total prescriptions increased 36%, versus the same period in 2023 CAPLYTA 2024 net product sales guidance raised to $650 to $680 million Announced positive Phase 3 results from Study 501 and Study 502 evaluating lumateperone as an adjunctive therapy to antidepressants in patients with major depressive disord ...

Financial Highlights Strong Recorded Music Subscription Streaming Growth Underpinned by a Robust Slate and Healthy Industry Trends Continued Momentum in Music Publishing Led by Strength in Digital and Performance Strong Margin Expansion and Double-Digit Growth in Operating and Free Cash Flow Reflect Solid Underlying Performance and Disciplined Cost Management Reiterating Full-Year Operating Cash Flow Conversion Guidance of 50-60% For the three months ended June 30, 2024 Total revenue decreased 1%, or increa ...

TROY, Mich., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Kelly (Nasdaq: KELYA, KELYB), a leading global specialty talent solutions provider, today announced it will participate in the Sidoti Virtual Investor Conference on Wednesday, August 14, 2024. Peter Quigley, president and chief executive officer, Olivier Thirot, executive vice president and chief financial officer, and Scott Thomas, head of investor relations, will participate in one-on-one meetings. Kelly's investor presentation is available on the company's w ...

MANITOWOC, Wisc., Aug. 07, 2024 (GLOBE NEWSWIRE) -- Orion Energy Systems, Inc. (NASDAQ:OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today reported results for its fiscal 2025 first quarter (Q1'25) ended June 30, 2024. Orion will hold an investor call today at 10:00 a.m. ET – details below. Orion is maintaining its revenue growth outlook of 10-15% which is expected to be more weighted to the second half of fis ...